                         SEQUENCE LISTING

<110>  The Scripps Research Institute
 
<120>  TARGETING JAML-CAR INTERACTIONS FOR TUMOR IMMUNOTHERAPY

<130>  1868.1PC

<140>  PCT/US2019/036121
<141>  2019-06-07

<150>  US 62/682,698
<151>  2018-06-08

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic sequence

<400>  1

Asp Tyr Gly Val His 
1               5   


<210>  2
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic sequence

<400>  2

Ile Ile Gly His Ala Gly Gly Thr Asp Tyr Asn Ser Asn Leu Lys Ser 
1               5                   10                  15      


<210>  3
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic sequence

<400>  3

His Phe Tyr Thr Tyr Phe Asp Val 
1               5               


<210>  4
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic sequence

<400>  4

Ser Gly Asp Lys Leu Ser Asp Val Tyr Val His 
1               5                   10      


<210>  5
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic sequence

<400>  5

Glu Asp Asn Arg Arg Pro Ser 
1               5           


<210>  6
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic sequence

<400>  6

Gln Ser Trp Asp Gly Thr Asn Ser Ala Trp Val 
1               5                   10      


